Discover medical breakthroughs and policy insights to stay informed on healthcare trends.
Pharmaceutical
British drugmaker GSK announced Wednesday that it will invest $30 billion in U.S. research, development, and supply chain infrastructure over the next five years, marking one of the company’s largest commitments to date. The move coincides with U.S. President Donald Trump’s second state visit to Britain,
Pharmaceutical
Eli Lilly announced Tuesday that it will invest $5 billion to build a new manufacturing facility in Goochland County, Virginia, aimed at boosting U.S. production of cutting-edge cancer drugs and other treatments. The project marks the first in a series of four new domestic sites the pharmaceutical giant plans
Pharmaceutical
Novartis announced Tuesday that it will acquire U.S.-based Tourmaline Bio in a deal valued at roughly $1.4 billion, as the Swiss pharmaceutical giant seeks to expand its cardiovascular drug portfolio. Under the agreement, Novartis will purchase Tourmaline Bio shares at $48 each, valuing the clinical-stage biopharma company
Hardware
At its “Awe-dropping” event on Tuesday, Apple introduced the long-anticipated third-generation AirPods Pro, marking the first major refresh of its flagship earbuds since 2022. Priced at $249, the new AirPods Pro bring health-focused sensors, smarter software features, and a sleeker design to Apple’s most advanced earbuds. Heart-Rate Tracking Arrives
Pharmaceutical
Biopharmaceutical giant Amgen announced Tuesday that it will invest more than $600 million to build a state-of-the-art research and development facility at its headquarters in Thousand Oaks, California. The move underscores the industry’s renewed push to strengthen U.S.-based operations amid mounting political pressure to reduce reliance on
Healthcare
Assort Health, a startup using artificial intelligence to automate patient communication for specialty healthcare practices, has raised about $50 million in a Series B round at a valuation of $750 million, according to three people familiar with the deal. The financing, led by Lightspeed Venture Partners, comes just four months
Pharmaceutical
AbbVie has agreed to acquire an experimental depression treatment from Gilgamesh Pharmaceuticals in a deal worth up to $1.2 billion, marking a significant step in the drugmaker’s push into next-generation psychiatric medicines. Under the agreement, AbbVie will acquire Gilgamesh’s lead asset, bretisilocin (GM-2505), an investigational therapy for
Health
The Food and Drug Administration (FDA) has approved the first-ever glucose monitoring system designed specifically for weight loss, developed by health-tech startup Signos. The decision, announced Wednesday, creates a new pathway for Americans seeking to manage their weight outside of traditional treatments like medication or surgery. A New Option Beyond
Pharmaceutical
Varda Space is pushing the boundaries of pharmaceutical production by taking the process out of Earth’s gravity well and into orbit. The company announced a $187 million Series C funding round on Thursday to accelerate its mission of using space as a unique environment for drug manufacturing. With gravity
Healthcare
In a striking show of investor confidence, AI health tech startup Abridge has doubled its valuation to $5.3 billion just four months after its previous funding round. The Pittsburgh-based company has secured a $300 million Series E round, led by Andreessen Horowitz with continued backing from Khosla Ventures, according
Health
Digital health startup Sword Health has secured a fresh $40 million in funding at a $4 billion valuation, marking a 33% increase from its $3 billion valuation just a year ago. The round was led by returning backer General Catalyst, with participation from Khosla Ventures, Comcast Ventures, and several other
Healthcare
In a bold move to solidify its international presence, Hims & Hers Health announced Tuesday it will acquire Zava, a prominent European telehealth platform. The acquisition marks a pivotal step in the U.S.-based company's strategy to expand beyond domestic borders and tap into growing demand for